Is That Daylight for ImClone?
The beleaguered drugmaker finally gets some good news with Swiss approval of its cancer-fighting drug Erbitux
Over the Rainbow Yet?
Consolidation slows, valuations grow, and now hope for some IPOs
With the necessary tools at hand, the race is on to build � and market � the first affordable, portable, fully functional DNA analyzer. Is the world ready?
Industry offers proposals to fight growing problem of fake drugs.
BAYER CHEMICALS TO TAKE A SPIN
Split-off of chemicals will shift firm�s focus to life sciences